Risk of PTSD Due to the Covid-19 Pandemic Among Patients in Opioid Substitution Treatment
Bibliographic Data
| ID | 15529753 |
|---|---|
| Authors | Isabella Fuchs (0000-0002-4354-4150, Johannes Kepler University of Linz), Isabella Fuchs-Leitner, Kurosch Yazdi (0000-0002-9940-9601, Johannes Kepler University of Linz, corresponding author), Nikolas W Gerstgrasser (Johannes Kepler University of Linz), Matthias G Tholen (0000-0001-8716-8807, Paracelsus Medical University), Sophie-Therés Graffius (Paracelsus Medical University), Alexander Schorb (0000-0002-3966-0108, Paracelsus Medical University), Jan Rosenleitner (0000-0002-3411-9160, Kepler Universitätsklinikum) |
| Year | 2021 |
| Volume | 12 |
| Pages | 729460-729460 |
| Publication date | 2021-09-30 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2021.729460 |
| PMID | 34658964 |
| OpenAlex | W3203770987 |
| Language | EN |
| Citations received | 1 |
| References cited | 45 |
Background: The impact of the COVID-19 pandemic on the mental health of patients suffering from addictive disorders is of major concern. This study aimed to explore the presence and potential increase in post-traumatic stress disorder (PTSD) symptoms, depression, and anxiety since the beginning of the pandemic for patients in opioid substitution therapy (OST). Methods: This cross-sectional survey study evaluated a clinical sample of patients in OST ( N = 123). Symptoms of post-traumatic stress disorder (PTSD) due to the COVID-19 pandemic were assessed by an adapted version of the impact of event scale (IES-R), resulting in two subgroups of low and high risk for PTSD. The depression, anxiety, and stress scale (DASS-21) was applied to collect data on the respective symptoms, and changes since the onset of the pandemic were reported on separate scales. Sociodemographic and COVID-19 related factors, as well as data on craving, consumption patterns, concomitant use, and the drug market were further assessed. Results: A binary logistic regression analysis confirmed the impact of self-perceived higher burden by psychological and economic factors on the elevated risk for PTSD due to the pandemic. The high-risk PTSD group also showed higher levels of depression, anxiety and stress, as well as a more pronounced deterioration in these symptoms since the pandemic. While reported levels of craving did not differ between the two groups, the high-risk PTSD group indicated a significantly higher increase in craving since the crisis, when compared to the low-risk group. Discussion: Our findings demonstrate elevated levels of clinical symptoms among patients in OST, with more than a quarter of patients found at risk for PTSD due to the COVID-19 pandemic. Furthermore, about 30-50% of our patients reported concerning levels of depression, anxiety, or stress. Special attention should be drawn to these findings, and potential deterioration of the situation should be addressed by health care facilities. Particularly, psychological, and financial burden due to the crisis were identified as factors increasing the risk for PTSD. These factors can easily be evaluated during routine anamneses, and might be a valuable source of information, when special attention is needed
Addiction · Anxiety · Coronavirus disease 2019 (COVID-19 · Craving · Depression (economics · Disease · Logistic regression · Mental health · Pandemic · Psychiatry · Clinical Psychology · COVID-19 and Mental Health · Medicine · Mental Health Treatment and Access · Posttraumatic Stress Disorder Research · Psychology · Internal Medicine
Statistical Power Analysis for the Behavioral Sciences
The Mental Health Consequences of Covid-19 and Physical Distancing
Mental health consequences during the initial stage of the 2020 Coronavirus pandemic (Covid-19) in Spain
Mitigating and learning from the impact of Covid‐19 infection on addictive disorders
Collision of the Covid-19 and Addiction Epidemics
Prevalence and predictors of PTSS during Covid-19 outbreak in China hardest-hit areas
Challenges in maintaining treatment services for people who use drugs during the Covid-19 pandemic
Evaluation of the Drug Use Disorders Identification Test (Dudit) in Criminal Justice and Detoxification Settings and in a Swedish Population Sample
Covid-19 risk and outcomes in patients with substance use disorders
The psychological impact of quarantine and how to reduce it
The short‐form version of the Depression Anxiety Stress Scales (Dass‐21)
Illicit drug use and harms in Australia in the context of Covid ‐19 and associated restrictions
Psychometric properties and measurement invariance of Depression, Anxiety and Stress Scales ( Dass ‐21) across cultures
The outbreak of Covid-19 coronavirus and its impact on global mental health
Developments in Drug Addiction During Covid-19—An Austrian Perspective Based on a Clinical Sample
Impact of the Covid-19 Pandemic on Patients With Alcohol Use Disorder and Associated Risk Factors for Relapse
Validation of the Impact of Event Scale With Modifications for Covid-19 (IES-Covid19)
Substance Use Disorders and Covid-19
Psychopathological Burden and Quality of Life in Substance Users During the Covid-19 Lockdown Period in Italy
Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (Covid-19) Epidemic among the General Population in China
A Nationwide Survey of Psychological Distress among Italian People during the Covid-19 Pandemic
| Citations per year | 0.33 |
|---|---|
| Citation span | 2023 - 2023 (1) |
| Highly cited | No |